Your search results are below. For a different search, enter another term below and click on the "Search" button:
-
861. Taiwan government bestows $760k grant to CellsMax Life for cancer detection platform — 4 insights
... efforts for its early cancer circulating tumor cell detection platform CellMax CMx. Here's what you should know: 1. The company is using its device initially to detect colorectal cancer. 2. The company ...15 June 2017 -
862. XBiotech discontinues its phase III trial & more — 6 GI company key notes
... for colorectal cancer. Takeda Pharmaceuticals is relocating approximately 100 researchers to Boston during fiscal year 2017. Boston Scientific is investing $19 million in a new Galway, Ireland-based ...14 June 2017 -
863. May, June 2017 Issue of Becker's ASC Revie
... GI & Endoscopy Colorectal Cancer Rates Up in Millennials — 5 Study Insights After years of decreases, colorectal cancer is re-emerging at alarming rates in the millennial generation. Click here ...13 June 2017 -
864. XBiotech discontinues phase III study for colorectal cancer antibody therapy — 4 insights
After early findings were "not sufficient to meet efficacy," XBiotech discontinued its phase III study of its novel candidate antibody therapy for colorectal cancer. Here's what you should know: 1. ...12 June 2017 -
865. New study aims to quantify cancer treatment cost — 4 insights
... are recruiting at least 370 patients with metastatic colorectal cancers to report on the financial hardships brought on by their care. 2. Researchers selected colorectal cancer because patients survive ...12 June 2017 -
866. Some stage III colorectal cancer may only need three months of chemotherapy — 5 study insights
A study, presented at the American Society of Clinical Oncology Annual Meeting, examined if researchers could reduce chemotherapy from six months to three months when treating stage III colorectal cancer ...08 June 2017 -
867. New research registry wants to provide insight into 'real world' management of metastatic colorectal cance
An observational research registry aims to provide insights into the management of metastatic colorectal cancer. Taiho Oncology is sponsoring the Choice Registry. The Choice Registry will examine clinical, ...31 May 2017 -
868. Defining gene signatures in colorectal cancer allows researchers to take personalized medicine approach — 3 insights
A study published in Nature Communications discovered how a genomic approach to colorectal cancer could improve a patient's prognosis and quality of life. Mark Lawler, PhD, lead study author and professor ...31 May 2017 -
869. Array BioPharma, Bristol-Myers Squibb collaborating to investigate metastatic colorectal cancer treatment — 4 key notes
... Opdivo + Yeroy regime. Researchers intended to see how the treatments will affect metastatic colorectal cancer patients with microsatellite stable tumors. Here's what you should know. 1. The companies ...31 May 2017 -
870. American Cancer Society Nutrition and Physical Activity guidelines increases colon cancer survival rates — 3 notes
Researchers conducted a study examining 2012 American Cancer Society Nutrition and Physical Activity guidelines' impact on colon cancer patients, according to American Journal of Managed Care. Researchers ...30 May 2017 -
871. Craig Campbell to hold 'Cornhole Challenge' for Fight Colorectal Cancer — 3 insight
Country music star Craig Campbell will host the 5th Annual Craig Campbell Celebrity Cornhole Challenge and the One Million Strong to benefit Fight Colorectal Cancer, Entertainment Focus reports. Here' ...30 May 2017 -
872. 2 approaches emerging as promising treatments for GI cancers — 7 insights
... currently treats multiple forms of leukemia. He submitted it to the FDA for colorectal cancer treatment and is currently awaiting approval. 4. Survival rate after CAR Ts treatment is higher than conventional ...30 May 2017 -
873. FDA approves cancer treatment for solid tumors with biomarkers — 4 key notes
... based on a tumor’s biomarker without regard to the tumor’s original location." 4. Colorectal, endometrial and gastrointestinal cancers all have tumors with biomarkers. Keytruda targets cellular pathways. ...24 May 2017 -
874. NJ administrators expect Allergan to make $385M+ impact over 20 years & more: 4 GI companies in the news
... which treats advanced colorectal cancer. More articles on gastroenterology: GI leader to know: Dr. Benjamin Schaus of Buffalo Gastroenterology Associates United Way recognizes Allergan for its positive ...24 May 2017 -
875. African Americans face higher interval colorectal cancers risk — 6 study insights
A study published in the Annals of Internal Medicine examined interval colorectal cancer risks in minorities. Stacey Fedewa, PhD, of the American Cancer Society, and colleagues conducted a population-based ...23 May 2017 -
876. European Medicines Agency's committee against approving XBiotech's Lead mAb Xilon
The European Medicines Agency's Committee for Medicinal Products for Human Use issued a negative opinion of XBiotech's Lead mAb Xilonix, which treats advanced colorectal cancer, GEN reports. GEN reports ...22 May 2017 -
877. Takeda reports strong FY 2016 & more: 4 GI companies making waves
... all tests to ensure C-scan system compliance. The companies are working to develop an ingestible capsule that will allow preparation-free colorectal cancer screening. Takeda Pharmaceuticals' gastroenterology, ...17 May 2017 -
878. Colorectal cancer patients' first degree relatives unaware of increased risk — 3 insights
A study published in the International Journal of Colorectal Disease examined colorectal patients' first degree relatives' screening rates. Dr. Ker-Kan Tan, of Singapore-based National University Cancer ...16 May 2017 -
879. National Cancer Institute awards $1.9M grant to PLx Pharma — 4 insights
The Bethesda, Md.-based National Cancer Institute awarded PLx Pharma a $1.9 million grant to support the drugmakers' aspirin for chemoprevention to treat colorectal cancer. Here's what you should know. ...15 May 2017 -
880. Drs. David Ahlquist & Anil Rustgi: 8 GI physicians in the headlines
... Ahlquist, MD, the William Beaumont Prize for discovering that multitarget DNA testing detects significantly more cancers and premalignant polyps in asymptomatic patients at average risk for colorectal ...12 May 2017